From todays press.
''The main loser among the top 200 this morning is CSL, which is down about 5 per cent after an Alzheimer's therapy by competitor Baxter failed in late stage trial.
This is seen as a blow for CSL as both the Australian company and Baxter stood to benefit from the potential use of immunoglobulin treatments in Alzheimer's patients.''
price drop, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.00 |
Change
2.260(0.78%) |
Mkt cap ! $141.5B | |||
| Open | High | Low | Value | Volume |
| $294.00 | $294.75 | $290.82 | $491.6M | 1.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8192 | $292.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.06 | 12368 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |